Pure Global

Visual Focused Play Intervention for Children With ADHD - Trial NCT06140979

Access comprehensive clinical trial information for NCT06140979 through Pure Global AI's free database. This phase not specified trial is sponsored by Xijing Hospital and is currently Not yet recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06140979
Not yet recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06140979
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Visual Focused Play Intervention for Children With ADHD
Efficacy of Visual Focusing Game on Children With Attention Deficit Hyperactivity Disorder and Mechanisms of Functional Near-Infrared Spectroscopic Imaging

Study Focus

Playing the game

Interventional

behavioral

Sponsor & Location

Xijing Hospital

Timeline & Enrollment

N/A

Nov 10, 2023

Jun 30, 2024

40 participants

Primary Outcome

Change in Attention Deficit Hyperactivity Disorder Rating Scale scores between baseline and post-treatment

Summary

This is a single-center, randomized, double-blind, sham-controlled study that will recruit
 children with attention deficit hyperactivity disorder and randomly assign them to a test
 group and a control group. The patients in the test group will be given a visual focus game
 to play and the patients in the control group will be given an animated video of the game
 that had no therapeutic effect. Treatment will be required at least 5 times per week for 2
 weeks, with each game or video session lasting 30 minutes. Clinical scales and functional
 near-infrared spectroscopic imaging will be performed before and at the end of the 2 weeks of
 treatment, respectively.

ICD-10 Classifications

Neurotic disorder, unspecified
Hyperkinetic disorder, unspecified
Habit and impulse disorder, unspecified
Mild cognitive disorder
Disturbance of activity and attention

Data Source

ClinicalTrials.gov

NCT06140979

Non-Device Trial